Luis Ramos-Ruperto

11PUBLICATIONS
33CO-AUTHORS
Pharmaceutical delivery technologiesPlanning and decision makingMedical virologyGene and molecular therapyBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 06, 2026
Preference for different PrEP formulations: A cross-sectional study in a PrEP cohort in Spain.

|Dec 08, 2025
Critical Appraisal Tools for Evaluating Artificial Intelligence in Clinical Studies: Scoping Review.

Juan B Cabello, Vicente Ruiz Garcia, Miguel Torralba

|Nov 28, 2025
Epidemiology and Risk Factors for HCV Infection Among MSM With or at Risk of HIV in Madrid (2022-2024).

Pablo Ryan, Juan Berenguer, Luis Ramos-Ruperto

|Mar 10, 2025
Three-Year Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide as a Switch Strategy in the Real World.

Alejandro de Gea-Grela, Rafael Micán, Rosa de Miguel

|May 15, 2024
Metabolic effects of switching to Biktarvy (B/F/TAF) in patients with HIV-1 treated with antiretroviral regimens that do not include tenofovir disoproxil fumarate (TDF) or tenofovir alafenamide (TAF): The Metabic study.

C Busca-Arenzana, D Ortega-González, M Díaz-Almirón

|Feb 21, 2024
Sex differences in the effectiveness and tolerability of dolutegravir plus rilpivirine as a switch strategy in people living with HIV.

Luis Ramos-Ruperto, Maria Del Mar Arcos-Rueda, Rosa de Miguel-Buckley

Pageof 2

Frequent Collaborators

3 joint publications

José Ignacio Bernardino

2 joint publications

Maria Del Mar Arcos-Rueda

2 joint publications

Rafael Mican-Rivera

1 joint publications

Ángel Robles-Marhuenda